An enigma of hypocalcaemia: unveiling the interaction between denosumab and intravenous iron when co-administered
Background: Denosumab is a human monoclonal antibody that works by binding to and inhibiting receptor activator of nuclear factor-κB ligand (RANKL), a protein crucial for osteoclast activity, thereby preventing osteoclast formation, function and survival, ultimately reducing bone resorption.1 In doi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Clinical Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1470211825000776 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|